HOME >> BIOLOGY >> NEWS
Influenza vaccine uses insect cells to speed development

nin.

The FluBlok vaccine has recently finished phase II clinical trials, where it has established safety and the ability to elicit a strong antibody response in humans.

"Since all the media used here are chemically stable and commercially available, the process can be easily scaled up for commercial manufacture," says Wang. "New FluBlok vaccines can be developed quickly and safely to address late appearing influenza viruses and to reduce the impact of a potential flu pandemic."


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
21-Mar-2005


Page: 1 2

Related biology news :

1. Evolving Issues in the Prevention and Treatment of Influenza: A media forum
2. Avian Influenza: Breaking News, Public Health and Surveillance Readiness
3. The Great Influenza wins 2005 Best Book Award from The National Academies
4. Confronting Influenza: Are We Prepared?
5. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
6. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
7. Handicapping tuberculosis may be the way to a better vaccine
8. Developing a more effective vaccine for tuberculosis
9. New target for HIV/AIDS drugs and vaccine discovered
10. Genomic analysis uncovers new targets for HIV vaccine
11. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):
(Date:8/17/2017)... ... August 17, 2017 , ... ... personalized medicine, today announced the launch of a new breast cancer monitoring study ... goal is to evaluate the potential for early detection of recurrent breast cancer ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... a different cell type. Many treatments for specific cancers, such as breast, prostate, ... targeted treatment is androgen deprivation therapy for advanced prostate cancer. , This ...
(Date:8/16/2017)... ... 2017 , ... We are proud to announce the successful ... Dilworth, MN site. The inspection took place Monday, July 31st through Friday, August ... a routine Bioresearch Monitoring Program (BIMO) with the USFDA wherein multiple Dermatology Vasoconstriction ...
(Date:8/15/2017)... 2017 After spending the past two years building a ... collection, GeneFo now offers this platform to healthcare stakeholders (hospitals, foundations, ... adherence, and data collection vis a vis their members, under their ... launch of this offer. ... ...
Breaking Biology Technology:
Cached News: